Health Care: Drugs

Albany Molecular Research Inc (AMRI: NASDAQ)

$18.99 -0.09 | -0.47%
04/27/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 276.57M 246.58M 226.69M 207.64M
Cost of Sales 183.54M 155.52M 150.73M 150.32M
Gross Operating Profit 93.03M 91.05M 75.95M 57.33M
Selling, General, and Administrative Expenses 50.52M 45.02M 44.05M 44.76M
Research & Development 1.00M 414.00K 906.00K 7.94M
Operating Income before D & A (EBITDA) 41.51M 45.62M 31.00M 4.64M
Depreciation & Amortization 25.66M 16.40M 17.33M 18.16M
Interest Income 3.00K 11.00K 9.00K 131.00K
Other Income - Net -9.91M 772.00K -130.00K 77.00K
Special Income / Charges -7.84M -1.86M -8.33M -21.34M
Total Income Before Interest Expenses (EBIT) -5.47M 20.96M 582.00K -35.92M
Interest Expense 0.00 1.26M 463.00K 714.00K
Pre-Tax Income -5.47M 19.70M 119.00K -36.64M
Income Taxes -2.19M 7.02M 3.90M -4.34M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -3.28M 12.68M -3.78M -32.30M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -3.28M 12.68M -3.78M -32.30M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -3.28M 12.68M -3.78M -32.30M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
8.14M 21.72M 9.19M -9.68M
Preferred Dividends
Net Income Available To Common -3.28M 12.68M -3.78M -32.30M
Basic EPS from Continuing Ops. -0.10 0.41 -0.12 -1.08
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.10 0.41 -0.12 -1.08
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.10 0.41 -0.12 -1.08
Basic Normalized Net Income/Share 0.26 0.70 0.30 -0.32
EPS fr Continuing Ops. -0.10 0.41 -0.12 -1.08
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.10 0.41 -0.12 -1.08
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 -0.01 0.00 0.00
EPS, Total -0.10 0.40 -0.12 -1.08
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.26 0.70 0.30 -0.32
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with AMRI

Latest AMRI Headlines from TheStreet

More Financial News for AMRI

Press Releases for AMRI

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter